Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naturalistic Substitution of Concerta in Adults with ADHD
NCT00302406Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2003
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Maintenance of symptom control at 6 weeks. Started Jul 2003; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00302406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302406.